The effects of caspofungin and voriconazole in experimental Candida endophthalmitis

Kusbeci T., Avci B. , Cetinkaya Z., Ozturk F., Yavas G., Ermis S. S. , ...More

CURRENT EYE RESEARCH, vol.32, no.1, pp.57-64, 2007 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 1
  • Publication Date: 2007
  • Doi Number: 10.1080/02713680601107157
  • Title of Journal : CURRENT EYE RESEARCH
  • Page Numbers: pp.57-64


Purpose: To evaluate the efficacy of newly developed antifungal agents caspofungin and voriconazole in Candida albicans endophthalmitis in rabbit eyes. Methods: Thirty New Zealand white rabbits were divided into four treatment groups and one control group. One eye of each rabbit was infected by inoculation of 1 x 10(4) CFU/ml of C. albicans. Seventy-two hours after the inoculation, caspofungin 100 mu g/0.1 ml in group 1 (n = 6), voriconazole 50 mu g/0.1 ml in group 2 (n = 6), amphotencin B 10 mu g/0.1 ml in group 3 (n = 6), itraconazole 10 mu g/0.1 ml in group 4 (n = 6), and 0.1 ml NaCl 0.9% in control group (n = 6) were injected into the vitreous cavity. Clinical and histopathologic examination scores and microbiological analysis of vitreous aspirates were compared. Results: There was statistically significant difference in the clinical scores, histopathologic scores, and mean CFU/ml between the treatment and control groups (p < 0.05). In caspofungin and voriconazole groups, histopathologic scores and mean CFU were lower than other treatment groups and control group. Conclusions: Intravitreal injection of caspofungin and voriconazole was effective against C. albicans endophthalmitis in this experimental rabbit model.